Matteo Simonelli

Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal

Patrick A. Ott, Sarina A. Piha‐Paul, Pamela N. Münster et al. · Annals of Oncology · 2017 · 253 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy

Paolo Andrea Zucali, Tommaso De Pas, Giovannella Palmieri et al. · Journal of Clinical Oncology · 2017 · 172 citations

Medicine, Oncology, Pharmacotherapy +13

Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience

Federico Pessina, Pierina Navarria, Luca Cozzi et al. · Journal of Neuro-Oncology · 2017 · 158 citations

Medicine, Oncology, Surgery +17

Retreatment with pemetrexed-based chemotherapy in patients with malignant pleural mesothelioma

Giovanni Luca Ceresoli, Paolo Andrea Zucali, Fabio De Vincenzo et al. · Lung Cancer · 2011 · 139 citations

Medicine, Oncology, Pharmacology +10

Treatment with pembrolizumab in programmed death ligand 1–positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE‐028 trial

David A. Reardon, Tae Min Kim, Jean‐Sébastien Frenel et al. · Cancer · 2021 · 121 citations · Full text

Medicine, Oncology, Pharmacotherapy +17